Navigation Links
Anti-Reticulin Antibody, IgA

ProductsAnti-Reticulin Antibody, IgA
Company ARUP Laboratories
Item Anti-Reticulin Antibody, IgA
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Adenovirus Antibody, IgG
2. Adenovirus Antibody, IgM
3. Anti-Cardiolipin Antibody, IgG
4. Anti-Cardiolipin Antibody, IgM
5. Anti-Centromere Antibody, IgG
6. Anti-dsDNA Antibody, IgG
7. Anti-GBM Antibody, IgA (IFA)
8. Anti-GBM Antibody, IgG (IFA)
9. Anti-GBM Antibody, IgG (ELISA)
10. Anti-Glomerular Basement Membrane Antibody, IgA (IFA)
11. Anti-Glomerular Basement Membrane Antibody, IgG (ELISA)
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products:
(Date:1/8/2009).../ -- Cephalon, Inc . (Nasdaq: CEPH ) today anno... CEO will present at the J.P. Morgan Healthcare C...rancisco, CA at approximately 4:00 p.m. Pacific Ti... webcast live on the investor relations section of...e archived for one week following the broadcast. ...
(Date:1/8/2009)...ides minimally-invasive treatment for Peripheral A...wire/ -- The Heart Hospital of Austin is the fir...s RF PowerAssert(TM) Magnetic Guidewire to success...mplete blockages in patients with peripheral arter...iologist, Frank Zidar, M.D. used the new device on...
(Date:1/8/2009)... , NEW YORK, Jan. 8 U...rations of North America today committed to raise ...ds in southern Israel, part of a major initiative ...uring the current conflict with Hamas, the terrori... , The funds will enhance programs supported by t...
(Date:1/8/2009)...l/ -- Wyeth (NYSE: WYE ) announced today that it...ce on Wednesday, January 14, 2009 at 11:30 a.m. Ea...mano, President, U.S. and Pharmaceutical Business ...entation will be webcast live for investors at ww...e conference. , , Wyeth is one of the world,s l...
Breaking Medicine News(10 mins):Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Heart Hospital of Austin First in World to Use New Device for Blocked Arteries 2Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2Health News:Wyeth to Present at the JP Morgan Healthcare Conference 2
... milk may reduce the risk of lung cancer. Studies ...cancer. Eating large amounts of fish could protect...arn that fish consumption may only have a moderati...s safe to carry on smoking as long as they eat fis...
...p the sickest patients, according to the latest re... alveoli - are progressively destroyed, leaving th...veryday activities like climbing stairs or carryin...med to suggest that lung reduction surgery was ben...
...ssel. This involves all layers of the vessel wall....ntial to rupture, thrombose or embolize. The most ...d thoracic aorta, and brain. Potential blood vesse...vasive techniques, but only if they are above a ce...
...mpered by high rates of relapse, even after prolon...Abuse Program of the VU Medical Center in the Neth...ional Institute on Drug Abuse (NIDA) have identifi...generation of medications to prevent relapse to co...
Other Medicine News:
(Date:1/6/2009)...wswire/ -- Sequella, Inc., a clinical-stage biopha...c potential, announced today that SQ109, its lead ...TB), was the first drug approved for evaluation in...ort Vaccine Company LLC and Quintiles Transnationa... of Allergy and Infectious Diseases (NIAID), Natio...
(Date:1/5/2009)...irstCall/ -- Micromet, Inc.,(Nasdaq: MITI ), a ...etary,antibodies for the treatment of cancer, inf...tlook on key events anticipated for the year 2009....on its research and development,programs at the f... Update on several preclinical BiTE antibodies at,...
(Date:12/27/2008)...re-FirstCall/ -- Warner Chilcott Limited (Nasdaq: ...ies and Mayne Pharma International Pty. Ltd. ("May...wsuits against each of Mutual Pharmaceutical Compa...Mylan") and Impax Laboratories, Inc. ("Impax") in... for infringement of Mayne,s U.S. Patent No. 6,958...
(Date:12/17/2008)...80 Percent of Trauma Patient,s Face Transplanted ,...ti-disciplinary team of doctors and surgeons at Cl...otal face transplant in the United States. , ...past two weeks, surgeons transplanted 80 percent o... -- essentially replacing her entire face, except ...
Breaking Medicine Technology:Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 3Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 71 1Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 71 2Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 71 3Annual General Meeting 28 22AGM 22 29 and Extraordinary General Meeting 28 22EGM 22 29 Notices Posted to Shareholders 67 1Annual General Meeting 28 22AGM 22 29 and Extraordinary General Meeting 28 22EGM 22 29 Notices Posted to Shareholders 67 2VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent 63 1VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent 63 2VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent 63 3Avitars Notes Significance of New On Site Oral Fluid Drug Testing Laws 59 1Avitars Notes Significance of New On Site Oral Fluid Drug Testing Laws 59 2